Cardiovascular Outcome Trials in Type 1 Diabetes: We Are Not There Yet

Affiliations

¹ University of Washington Diabetes Institute, University of Washington School of Medicine, Seattle, WA.
² University of Colorado Anschutz Medical Campus, Aurora, CO.

Editorial

Irl B Hirsch et al. Diabetes Care. 2025.

. 2025 Sep 1;48(9):1481-1483.

doi: 10.2337/dci25-0062.

¹ University of Washington Diabetes Institute, University of Washington School of Medicine, Seattle, WA.
² University of Colorado Anschutz Medical Campus, Aurora, CO.

No abstract available

Comment on

Cardiovascular Outcomes and Efficacy of the PCSK9 Inhibitor Evolocumab in Individuals With Type 1 Diabetes: Insights From the FOURIER Trial.
Kang YM, Giugliano RP, Ran X, Deedwania P, De Ferrari GM, George JT, Gouni-Berthold I, Paiva da Silva Lima G, Handelsman Y, Lewis BS, Ohman EM, Wang H, López JAG, Monsalvo ML, Sabatine MS, Leiter LA. Kang YM, et al. Diabetes Care. 2025 Sep 1;48(9):1512-1516. doi: 10.2337/dc25-0942. Diabetes Care. 2025. PMID: 40544474 Clinical Trial.